Tissue factor-dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by Shiga toxigenic Escherichia coli

Journal of Infectious Diseases

Volumn 202, Issue 9, 2010, Pages 1415-1423

  Wang, Hui ^a   Paton, James C ^a   Thorpe, Cheleste M ^b   Bonder, Claudine S ^a   Sun, Wai Yan ^a   Paton, Adrienne W ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; GLUCOSE REGULATED PROTEIN 78; MESSENGER RNA; PROCOAGULANT; SUBTILASE CYTOTOXIN; THROMBOPLASTIN; UNCLASSIFIED DRUG; ESCHERICHIA COLI PROTEIN; HEAT SHOCK PROTEIN; MOLECULAR CHAPERONE GRP78; SUBTILASE CYTOTOXIN, E COLI; SUBTILISIN;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; UPREGULATION; ANIMAL; BIOSYNTHESIS; BLOOD CLOTTING; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION PROFILING; METABOLISM; MOUSE; PATHOGENICITY; THROMBOSIS; TOXICITY;

ANIMALS; BLOOD COAGULATION; CELLS, CULTURED; ENDOTHELIAL CELLS; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION PROFILING; HEAT-SHOCK PROTEINS; HUMANS; MACROPHAGES; MICE; SHIGA-TOXIGENIC ESCHERICHIA COLI; SUBTILISINS; THROMBOPLASTIN; THROMBOSIS;

EID: 77958085553     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/656534     Document Type: Article

References (29)

1. Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998; 11:450-479.
2. 5 cytotoxins produced by Shiga toxigenic Escherichia coli. J Exp Med 2004; 200:35-46.
3. Paton AW, Woodrow MC, Doyle RM, Lanser JA, Paton JC. Molecular characterization of a Shiga-toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome. J Clin Microbiol 1999; 37:3357-3361.
4. 5 toxin that targets the endoplasmic reticulum. J Infect Dis 2007; 196:1093-1101.
5. 5 toxin that targets the endoplasmic reticulum chaperone BiP. Cell Microbiol 2008; 10:795-806.
6. Paton AW, Beddoe T, Thorpe CM, et al. AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature 2006; 443:548-552. (Pubitemid 44527286)
7. Lee AS. The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci 2001; 26:504-510. (Pubitemid 32735452)
8. Watson LM, Chan AK, Berry LR, et al. Overexpression of the 78-kDa glucose-regulated protein/immunoglobulin-binding protein (GRP78/BiP) inhibits tissue factor procoagulant activity. J Biol Chem 2003; 278:17438-17447.
9. Bhattacharjee G, Ahamed J, Pedersen B, et al. Regulation of tissue factor-mediated initiation of the coagulation cascade by cell surface grp78. Arterioscler Thromb Vasc Biol 2005; 25:1737-1743. (Pubitemid 41098949)
10. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 1994; 8:385-390. (Pubitemid 24155950)
11. Tremoli E, Camera M, Toschi V, Colli S. Tissue factor in atherosclerosis. Atherosclerosis 1999; 144:273-283.
12. Miller CL, Graziano C, Lim RC, Chin M. Generation of tissue factor by patient monocytes: correlation to thromboembolic complications. Thromb Haemost 1981; 46:489-495. (Pubitemid 11049514)
13. Levi M. The coagulant response in sepsis and inflammation. Hamostaseologie 2010; 30:10-16.
14. Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983; 49:5-7. (Pubitemid 13144355)
15. Nakagomi A, Sasaki M, Ishikawa Y, et al. Upregulation of monocyte tissue factor activity is significantly associated with low-grade chronic inflammation and insulin resistance in patients with metabolic syndrome. Circ J 2010; 74:572-577.
16. Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol 2009; 27:4834-4838.
17. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nature Med 2003; 9:458-462. (Pubitemid 36460081)
18. Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005; 96:1233-1239. (Pubitemid 40962100)
19. Talbot UM, Paton JC, Paton AW. Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli. Infect Immun 2005; 73:4432-4436.
20. Litwin M, Clark K, Noack L, et al. Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31). J Cell Biol 1997; 139:219-228. (Pubitemid 27444093)
21. Applied Biosystems. User bulletin no. 2: ABI Prism 7700 Sequence Detection System. Applied Biosystems Web site. http://docs.appliedbiosystems. com/pebiodocs/04303859.pdf. Published 11 December 1997. Updated October 2001. Accessed 2003.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
23. Erlich J, Fearns C, Mathison J, Ulevitch RJ, Mackman N. Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun 1999; 67:2540-2546. (Pubitemid 29200516)
24. Brutzki TC, Kulczycky MJ, Bardossy L, Clarke BJ, Blajchman MA. Rapid in vivo induction of leukocyte tissue factor mRNA and protein synthesis following low dose endotoxin administration to rabbits. Hematol J 2001; 2:188-195. (Pubitemid 32633670)
25. Sugatani J, Igarashi T, Munakata M, et al. Activation of coagulation in C57BL/6 mice given verotoxin 2 (VT2) and the effect of co-administration of LPS with VT2. Thromb Res 2000; 100:61-72.
26. Pozza LM, Austin RC. Getting a GRP on tissue factor activation. Arterioscler Thromb Vasc Biol 2005; 25:1529-1531.
27. Wolfson J, Thorpe CM, May KL, et al. Subtilase cytotoxin activates PERK, ATF6 and IRE1 endoplasmic reticulum stress-signaling pathways. Cell Microbiol 2008; 10:1775-1786.
28. Yamazaki H, Hiramatsu N, Hayakawa K, et al. Activation of the Akt-NF-κB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response. J Immunol 2009; 183:1480-1487.
29. Nestoridi E, Tsukurov O, Kushak RI, Ingelfinger JR, Grabowski EF. Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome. J Thromb Haemost 2005; 3:752-762. (Pubitemid 41647890)